X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs JUBILANT LIFE SCIENCES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA JUBILANT LIFE SCIENCES ABBOTT INDIA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 42.0 26.0 161.7% View Chart
P/BV x 10.5 5.3 196.7% View Chart
Dividend Yield % 0.6 0.3 187.7%  

Financials

 ABBOTT INDIA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
JUBILANT LIFE SCIENCES
Mar-14
ABBOTT INDIA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs6,015187 3,220.0%   
Low Rs3,70765 5,694.3%   
Sales per share (Unadj.) Rs1,236.9364.3 339.5%  
Earnings per share (Unadj.) Rs122.26.8 1,784.7%  
Cash flow per share (Unadj.) Rs129.024.5 526.5%  
Dividends per share (Unadj.) Rs35.003.00 1,166.7%  
Dividend yield (eoy) %0.72.4 30.2%  
Book value per share (Unadj.) Rs521.2164.9 316.1%  
Shares outstanding (eoy) m21.25159.28 13.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.90.3 1,136.9%   
Avg P/E ratio x39.818.4 216.3%  
P/CF ratio (eoy) x37.75.1 733.1%  
Price / Book Value ratio x9.30.8 1,221.0%  
Dividend payout %28.643.8 65.4%   
Avg Mkt Cap Rs m103,29620,061 514.9%   
No. of employees `0003.06.2 47.8%   
Total wages/salary Rs m3,37011,052 30.5%   
Avg. sales/employee Rs Th8,891.89,383.0 94.8%   
Avg. wages/employee Rs Th1,140.01,786.9 63.8%   
Avg. net profit/employee Rs Th878.3176.3 498.2%   
INCOME DATA
Net Sales Rs m26,28458,034 45.3%  
Other income Rs m504191 264.6%   
Total revenues Rs m26,78958,224 46.0%   
Gross profit Rs m3,6655,786 63.3%  
Depreciation Rs m1442,812 5.1%   
Interest Rs m83,237 0.3%   
Profit before tax Rs m4,017-72 -5,571.8%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m1,421696 204.0%   
Profit after tax Rs m2,5961,090 238.1%  
Gross profit margin %13.910.0 139.9%  
Effective tax rate %35.4-965.9 -3.7%   
Net profit margin %9.91.9 525.7%  
BALANCE SHEET DATA
Current assets Rs m14,44629,280 49.3%   
Current liabilities Rs m4,72538,912 12.1%   
Net working cap to sales %37.0-16.6 -222.9%  
Current ratio x3.10.8 406.3%  
Inventory Days Days5184 60.9%  
Debtors Days Days2051 38.6%  
Net fixed assets Rs m1,11355,712 2.0%   
Share capital Rs m213155 137.5%   
"Free" reserves Rs m10,80820,968 51.5%   
Net worth Rs m11,07626,265 42.2%   
Long term debt Rs m017,169 0.0%   
Total assets Rs m16,24188,606 18.3%  
Interest coverage x497.01.0 50,828.4%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x1.60.7 247.1%   
Return on assets %16.04.9 328.3%  
Return on equity %23.44.2 564.6%  
Return on capital %36.311.6 314.2%  
Exports to sales %0.637.8 1.6%   
Imports to sales %12.616.5 76.7%   
Exports (fob) Rs m16221,933 0.7%   
Imports (cif) Rs m3,3229,567 34.7%   
Fx inflow Rs m26822,004 1.2%   
Fx outflow Rs m3,92711,749 33.4%   
Net fx Rs m-3,65910,255 -35.7%   
CASH FLOW
From Operations Rs m2,5148,026 31.3%  
From Investments Rs m-800-1,744 45.8%  
From Financial Activity Rs m-803-4,447 18.1%  
Net Cashflow Rs m9121,834 49.7%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 75.0 3.5 2,142.9%  
Indian inst/Mut Fund % 7.9 8.7 90.8%  
FIIs % 0.1 21.2 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 21.1 81.0%  
Shareholders   18,270 23,815 76.7%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   STERLING BIOTECH  SANOFI INDIA  PANACEA BIOTECH  ORCHID PHARMA LTD  NOVARTIS  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 19, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS